|
⚲
|
| Keyboard |
| Prudo-Chlebosz Raymond
✚
|
|
|---|---|
| CIK # | 0001653262 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001653262] | |
| 4 | [0001653262] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Morria Biopharmaceuticals PLC | |
| Prudo-Chlebosz Raymond |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Morria Biopharmaceuticals PLC AKTX
Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 386,661 | ||
|
Morria Biopharmaceuticals PLC AKTX
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
|
2025-12-16 | Buy | 618,658 | ||
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 386,661 | $0.40 | 154,664 |
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 618,658 | $0.40 | 247,463 |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 175,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 225,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Series A Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 446,428 | $1.12 | 499,999 |
|
Morria Biopharmaceuticals PLC AKTX
American Depositary Shares representing Ordinary Shares
|
2025-03-06 | Grant | 446,428 | $1.12 | 499,999 |
|
Morria Biopharmaceuticals PLC AKTX
Series B Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 446,428 | $1.12 | 499,999 |
|
Morria Biopharmaceuticals PLC AKTX
Warrants (Right to Buy) · derivative
|
2024-12-02 | Grant | 419,286,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-12-02 | Grant | 419,286,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2024-06-28 | Grant | 10,000,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Ordinary Shares, par value $0.0001 per share
|
2024-05-31 | Grant | 1,326,258,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Warrants (Right to Buy) · derivative
|
2024-05-31 | Grant | 1,326,258,000 | $0.00 |